Physician profile
Sol C Moon
NPI 1578198404
$2,102.45
in general payments reported to CMS, 2019-2025
8 companies · $951 in 2025
The $951 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $574 · 2024: $577 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $666.93 | 2023-2025 | Ams 700, Lithovue, Axonics |
| Axonics, INC. | $391.75 | 2023-2024 | Axonics, Bulkamid |
| Coloplast Corp | $329.41 | 2025 | |
| Endo USA, INC. | $239.98 | 2024-2025 | Xiaflex |
| Urogen Pharma, INC. | $149.21 | 2025 | |
| Astellas Pharma Global Development | $125.65 | 2024 | Xtandi |
| Astellas Pharma US INC | $112.35 | 2023 | Xtandi |
| Karl Storz Endoscopy-America | $87.17 | 2023 | Flex-X / Image 1 S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sol Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.